Publicacions en col·laboració amb investigadors/es de University of Paris-Sorbonne (2)

2024

  1. Prediction of individual lifetime cardiovascular risk and potential treatment benefit: Development and recalibration of the LIFE-CVD2 model to four European risk regions

    European Journal of Preventive Cardiology, Vol. 31, Núm. 14, pp. 1690-1699

  2. Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study

    British Journal of Dermatology, Vol. 191, Núm. 3, pp. 419-427